Stan Erck

Track

Insider profile

Currently holds positions in BioCryst Pharmaceuticals Inc and Novavax Inc

Positions

Position Company Period
Independent Director BioCryst Pharmaceuticals Inc Dec. 22, 2008 -
President, Chief Executive Officer, Director Novavax Inc April 19, 2011 -
Stan Erck's trades of MaxCyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-13 2025-08-13
US MaxCyte Inc (MXCT)
B Purchase
61,204 +18.6%
97.53
US$2,092,104 		61,204 +18.6% 97.53 US$2,092,104
2024-11-06 2024-11-01
US MaxCyte Inc (MXCT)
S Sale
88,953
104.46
US$1,983,672 		88,953 104.46 US$1,983,672
2024-11-05 2024-11-01
US MaxCyte Inc (MXCT)
PlS Planned sale
21,953 -33.7%
165.05
US$3,034,740 		21,953 -33.7% 165.05 US$3,034,740
2024-10-03 2024-10-02
US MaxCyte Inc (MXCT)
S Sale
21,607
3.71
US$80,229 		21,607 3.71 US$80,229
2024-10-02 2024-10-02
US MaxCyte Inc (MXCT)
PlS Planned sale
21,607 -7.4%
3.71
US$80,162 		21,607 -7.4% 3.71 US$80,162
2024-10-03 2024-10-01
US MaxCyte Inc (MXCT)
S Sale
26,082
3.78
US$98,548 		26,082 3.78 US$98,548
2024-10-02 2024-10-01
US MaxCyte Inc (MXCT)
PlS Planned sale
26,082 -8.8%
3.78
US$98,590 		26,082 -8.8% 3.78 US$98,590
2024-09-06 2024-09-04
US MaxCyte Inc (MXCT)
S Sale
29,767
3.97
US$118,133 		29,767 3.97 US$118,133
2024-09-05 2024-09-04
US MaxCyte Inc (MXCT)
PlS Planned sale
29,767 -10.0%
3.97
US$118,175 		29,767 -10.0% 3.97 US$118,175
2024-09-06 2024-09-03
US MaxCyte Inc (MXCT)
S Sale
17,922
4.10
US$73,441 		17,922 4.10 US$73,441
2024-09-05 2024-09-03
US MaxCyte Inc (MXCT)
PlS Planned sale
17,922 -6.2%
4.10
US$73,480 		17,922 -6.2% 4.10 US$73,480
2024-09-03 2024-09-03
US MaxCyte Inc (MXCT)
PrS Proposed sale
143,067
4.32
US$618,049 		143,067 4.32 US$618,049
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
500 -2.1%
180.58
US$90,290 		500 -2.1% 180.58 US$90,290
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
3,300 -11.9%
179.48
US$592,282 		3,300 -11.9% 179.48 US$592,282
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
8,563 -23.6%
178.46
US$1,528,182 		8,563 -23.6% 178.46 US$1,528,182
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
8,890 -19.7%
177.58
US$1,578,724 		8,890 -19.7% 177.58 US$1,578,724
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
4,700 -9.4%
176.48
US$829,434 		4,700 -9.4% 176.48 US$829,434
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
3,600 -6.7%
175.61
US$632,198 		3,600 -6.7% 175.61 US$632,198
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
3,100 -5.5%
174.56
US$541,142 		3,100 -5.5% 174.56 US$541,142
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
5,038 -8.2%
173.45
US$873,829 		5,038 -8.2% 173.45 US$873,829
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
3,746 -5.7%
172.36
US$645,672 		3,746 -5.7% 172.36 US$645,672
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PlS Planned sale
1,392 -2.1%
166.98
US$232,441 		1,392 -2.1% 166.98 US$232,441
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
472 -1.9%
190.63
US$89,978 		472 -1.9% 190.63 US$89,978
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
1,502 -5.8%
189.47
US$284,584 		1,502 -5.8% 189.47 US$284,584
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
100 -0.4%
187.95
US$18,795 		100 -0.4% 187.95 US$18,795
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
8 -0.0%
185.71
US$1,486 		8 -0.0% 185.71 US$1,486
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
192 -0.7%
183.61
US$35,253 		192 -0.7% 183.61 US$35,253
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
300 -1.1%
182.40
US$54,721 		300 -1.1% 182.40 US$54,721
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
1,600 -5.7%
181.21
US$289,934 		1,600 -5.7% 181.21 US$289,934
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
2,541 -8.3%
180.42
US$458,457 		2,541 -8.3% 180.42 US$458,457
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
1,323 -4.1%
179.29
US$237,200 		1,323 -4.1% 179.29 US$237,200
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
4,604 -12.6%
178.27
US$820,753 		4,604 -12.6% 178.27 US$820,753
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
6,227 -14.6%
177.37
US$1,104,474 		6,227 -14.6% 177.37 US$1,104,474
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
2,601 -5.7%
176.24
US$458,388 		2,601 -5.7% 176.24 US$458,388
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
3,602 -7.4%
175.15
US$630,878 		3,602 -7.4% 175.15 US$630,878
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
5,853 -10.7%
174.30
US$1,020,176 		5,853 -10.7% 174.30 US$1,020,176
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
3,002 -5.2%
173.16
US$519,834 		3,002 -5.2% 173.16 US$519,834
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
4,103 -6.6%
172.02
US$705,815 		4,103 -6.6% 172.02 US$705,815
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
2,602 -4.0%
171.34
US$445,814 		2,602 -4.0% 171.34 US$445,814
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
901 -1.4%
170.07
US$153,233 		901 -1.4% 170.07 US$153,233
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
1,959 -2.9%
169.05
US$331,175 		1,959 -2.9% 169.05 US$331,175
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
2,801 -4.0%
167.88
US$470,240 		2,801 -4.0% 167.88 US$470,240
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
1,100 -1.5%
166.62
US$183,286 		1,100 -1.5% 166.62 US$183,286
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
904 -1.3%
165.68
US$149,777 		904 -1.3% 165.68 US$149,777
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PlS Planned sale
703 -1.0%
164.74
US$115,812 		703 -1.0% 164.74 US$115,812